Introduction to Erlolieva 150mg Tablet
Erlolieva 150mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer. Erlolieva 150mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. Doctors will periodically monitor kidney and liver function. Inform the physician about any history of clotting disorders or medicines taken for clotting disorders, as the Erlolieva 150mg Tablet may increase the tendency to bleed.
Inform the physician if patients develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine. Patients are advised not to smoke while treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.
Uses of Erlolieva 150mg Tablet
- Advanced or metastatic non-small lung cancer (NSCLC)
- Advanced or metastatic pancreatic cancer
Therapeutic Effects of Erlolieva 150mg Tablet
Erlolieva 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Interaction of Erlolieva 150mg Tablet with other drugs
Inform the doctor about any medications you are taking or have taken before the treatment
More Information about Erlolieva 150mg Tablet
Keep out of sight and reach of children. Store at controlled room temperature between 15°C to 30°C. Do not freeze.
How to consume Erlolieva 150mg Tablet
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact the doctor if any missed dose or taken more.
Customer Reviews
Write a review
Cobus Bester
Cobus Bester on Mar 03, 2023
Can’t wait to start mixin’ with this one! Irba-irr-Up-up-up-up-date your theme!
Report as Inappropriate